
As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent.

There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers.

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world.

A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk.

As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent.

There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers.

Since Watson and Crick discovered DNA's double helix structure in 1953, the US has been a leader in biotechnology innovation. American excellence in this field has greatly benefited people around the world.

A troubling disconnect between medical expertise and insurance mandates is putting patients' health at risk.

As the global population approaches 10 billion by 2050, the challenge of providing safe, nutritious food is growing more urgent.

There are over 7000 rare diseases identified in the U.S. alone. Many of these diseases affect children, leaving families desperate for answers.